Financhill
Back

Palvella Therapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
15

PVLA
Palvella Therapeutics, Inc.

Last Price:
$100.96
Seasonality Move:
132.75%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PVLA is experiencing slight selling pressure.

Palvella Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 100.96 Buy
20-day SMA: 97.92 Buy
50-day SMA: 88.21 Buy
200-day SMA: 49.49 Buy
8-day EMA: 88.49 Buy
20-day EMA: 55.96 Buy
50-day EMA: 27.72 Buy
200-day EMA: 7.77 Buy

Palvella Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 28.47 Buy
Relative Strength Index (14 RSI): 54.8 Buy
Chaikin Money Flow: -12028 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (93.33 - 102.53) Buy
Bollinger Bands (100): (54.32 - 91.26) Buy

Palvella Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Palvella Therapeutics, Inc. Stock

Is Palvella Therapeutics, Inc. Stock a Buy?

PVLA Technical Analysis vs Fundamental Analysis

Sell
15
Palvella Therapeutics, Inc. (PVLA) is a Sell

Is Palvella Therapeutics, Inc. a Buy or a Sell?

Palvella Therapeutics, Inc. Stock Info

Market Cap:
1.2B
Price in USD:
101.15
Share Volume:
175K

Palvella Therapeutics, Inc. 52-Week Range

52-Week High:
114.69
52-Week Low:
11.17
Sell
15
Palvella Therapeutics, Inc. (PVLA) is a Sell

Palvella Therapeutics, Inc. Share Price Forecast

Is Palvella Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Palvella Therapeutics, Inc.

Is Palvella Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.53 per share.

Technical Analysis of Palvella Therapeutics, Inc.

Should I short Palvella Therapeutics, Inc. stock?

* Palvella Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.